Clinical trial
Permeability Factor in Focal Segmental Glomerulosclerosis
NCT00007475 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00007475 |
|---|---|
| Title | Permeability Factor in Focal Segmental Glomerulosclerosis |
| Official title | Permeability Factor in Focal Segmental Glomerulosclerosis |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Focal Segmental Glomerulosclerosis |
| Intervention type | Drug, Procedure |
| Interventions | Plasma exchange, Cyclophosphamide |
| Enrollment | 15 |
| Start date | Dec 1, 2000 |
| Primary completion | Jun 1, 2014 |
| Completion | Jun 1, 2014 |
| First posted | Dec 25, 2000 |
| Last update posted | Feb 10, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: